Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

Investor Grievance Report As Per Regulation 13(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 As required by Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below Statement of Investor Complaints for the quarter ended 30th September, 2017. Particulars Numbers Pending as on 1st July, 2017 0 Received during the quarter 0 Disposed of during the quarter 0 Unresolved as on 30th September, 2017 0
10-10-2017
Bigul

Sun Pharma Advanced Research shares tank 15.6%

 Shares of Sun Pharma Advanced Research Company (SPARC) today slumped nearly 16 per cent after the company said its pivotal studies on treatment of spasticity in patients with multiple sclerosis did...
09-10-2017
Bigul

Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that all activities in relation to both physical and electronic share transfer facility during the period April 01, 2017 to September 30, 2017 (both days inclusive) are maintained by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar &...
07-10-2017
Bigul

Credit Rating

 Sun Pharmaceutical Industries Limited has informed the Exchange regarding Credit Rating of Commercial Paper of the Company by CRISIL.
04-10-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raksha Valia
03-10-2017
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Valia
28-09-2017
Bigul

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Sun Pharmaceutical Industries Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
28-09-2017
Bigul

Scrutinizer's Report

 Voting Results of Twenty Fifth Annual General Meeting of the Company held on September 26, 2017 along with Scrutinizer's Report.
27-09-2017
Bigul

Speciality segment a key growth driver: Sun Pharma

 The company's speciality initiatives target the global market with the US being one of the important markets, Shanghvi said
26-09-2017
Bigul

25Th AGM Speech - SPIL

 Chairman Speech made at 25th AGM as on 26 September 2017
26-09-2017
Next Page
Close

Let's Open Free Demat Account